Meeting the Challenge: Prevention of Pneumococcal Disease with Conjugate Vaccines
Fuente:
Redalyc
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artículo científico |
| Lingua: | en |
| Pubblicazione: |
Instituto Nacional de Salud Pública
2001
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1876461882657734656 |
|---|---|
| author | Irma Gabriela Echániz Avilés |
| author_facet | Irma Gabriela Echániz Avilés |
| contents | Meeting the Challenge: Prevention of Pneumococcal Disease with Conjugate Vaccines Irma Gabriela Echániz Avilés Fortino Solórzano Santos Salud Streptococcus pneumoniae is one of the leading causes of bothinvasive and noninvasive diseases in the pediatric populationand continues to represent a significant public healthburden worldwide. The increasing incidence of antibioticresistantstrains of the pathogen has complicated treatmentand management of the various pneumococcal diseasemanifestations. Thus, the best management strategy may bethe prevention of pneumococcal diseases throughvaccination. Although several pneumococcal conjugatevaccines have been clinically studied in infants and children,only a 7-valent conjugate vaccine (PNCRM7; Prevnar®/Prevenar®) is currently approved for the prevention ofinvasive disease. Vaccination with PNCRM7 is safe andeffective in infants and young children. Routine vaccinationwith the conjugate vaccine could improve outcomes by safeguardingagainst the development of antibiotic-resistantstrains of S. pneumoniae, thus simplifying the managementof pneumococcal disease. Additionally, the overall costsassociated with the treatment of pneumococcal diseasescould be substantially reduced, particularly in developingcountries. The time has come for fully applying this newadvancement against S. pneumoniae, to benefit the childrenof the world. The Spanish version of this paper is availableat: http://www.insp.mx/salud/index.htmlKey words: pneumococcal infections; Streptococcuspneumoniae; infant; vaccines 2001 artículo científico 0036-3634 https://www.redalyc.org/articulo.oa?id=10643414 en http://www.redalyc.org/revista.oa?id=106 Salud Pública de México application/pdf Instituto Nacional de Salud Pública Salud Pública de México (México) Num.4 Vol.43 |
| format | Artículo científico |
| id | redalyc_10643414 |
| institution | Redalyc |
| language | en |
| publishDate | 2001 |
| publisher | Instituto Nacional de Salud Pública |
| spellingShingle | Meeting the Challenge: Prevention of Pneumococcal Disease with Conjugate Vaccines Irma Gabriela Echániz Avilés Salud Meeting the Challenge: Prevention of Pneumococcal Disease with Conjugate Vaccines Irma Gabriela Echániz Avilés Fortino Solórzano Santos Salud Streptococcus pneumoniae is one of the leading causes of bothinvasive and noninvasive diseases in the pediatric populationand continues to represent a significant public healthburden worldwide. The increasing incidence of antibioticresistantstrains of the pathogen has complicated treatmentand management of the various pneumococcal diseasemanifestations. Thus, the best management strategy may bethe prevention of pneumococcal diseases throughvaccination. Although several pneumococcal conjugatevaccines have been clinically studied in infants and children,only a 7-valent conjugate vaccine (PNCRM7; Prevnar®/Prevenar®) is currently approved for the prevention ofinvasive disease. Vaccination with PNCRM7 is safe andeffective in infants and young children. Routine vaccinationwith the conjugate vaccine could improve outcomes by safeguardingagainst the development of antibiotic-resistantstrains of S. pneumoniae, thus simplifying the managementof pneumococcal disease. Additionally, the overall costsassociated with the treatment of pneumococcal diseasescould be substantially reduced, particularly in developingcountries. The time has come for fully applying this newadvancement against S. pneumoniae, to benefit the childrenof the world. The Spanish version of this paper is availableat: http://www.insp.mx/salud/index.htmlKey words: pneumococcal infections; Streptococcuspneumoniae; infant; vaccines 2001 artículo científico 0036-3634 https://www.redalyc.org/articulo.oa?id=10643414 en http://www.redalyc.org/revista.oa?id=106 Salud Pública de México application/pdf Instituto Nacional de Salud Pública Salud Pública de México (México) Num.4 Vol.43 |
| title | Meeting the Challenge: Prevention of Pneumococcal Disease with Conjugate Vaccines |
| topic | Salud |
| url | https://www.redalyc.org/articulo.oa?id=10643414 |